Dr. Todd Schlesinger is a board-cerJfied dermatologist, Mohs surgeon and clinical invesJgator. He completed his residency at the Cleveland Clinic Foundation and is the founder of a three-office dermatology and dermatologic surgery practice (now part of Epiphany Dermatology) and clinical research center. His areas of
research focus are inflammatory dermatoses, cutaneous oncology, and cosmetic dermatology. He is the author of over 100 peer-reviewed publications as well as several book chapters and numerous presentations and posters at national and international conferences. He is past president of the South Carolina Medical
AssociaJon, the South Carolina Academy of Dermatology and Dermatologic Surgery, and the past Editor in Chief of the AAD’s ongoing member CME program Dialogues in Dermatology. He is currently serving as a member of the AAD Board of Directors, one of three Scientific Directors at Facial Aesthetic Conference and
ExhibiJon (F.A.C.E.) in London, a Scientific Committee Member at IMCAS World Conference, and on the Advisory Board of LiVDerm.
Dr. Todd Schlesinger is a board-cerJfied dermatologist, Mohs surgeon and clinical invesJgator. He completed his residency at the Cleveland Clinic Foundation and is the founder of a three-office dermatology and dermatologic surgery practice (now part of Epiphany Dermatology) and clinical research center. His areas of
research focus are inflammatory dermatoses, cutaneous oncology, and cosmetic dermatology. He is the author of over 100 peer-reviewed publications as well as several book chapters and numerous presentations and posters at national and international conferences. He is past president of the South Carolina Medical
AssociaJon, the South Carolina Academy of Dermatology and Dermatologic Surgery, and the past Editor in Chief of the AAD’s ongoing member CME program Dialogues in Dermatology. He is currently serving as a member of the AAD Board of Directors, one of three Scientific Directors at Facial Aesthetic Conference and
ExhibiJon (F.A.C.E.) in London, a Scientific Committee Member at IMCAS World Conference, and on the Advisory Board of LiVDerm.